|
Oct 23
|
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
|
|
Jul 23
|
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
|
|
Jul 23
|
EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder
|
|
Jun 20
|
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
|
|
Jun 20
|
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
|
|
May 29
|
Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th
|
|
May 15
|
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
Apr 22
|
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
|
|
Apr 22
|
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
|
|
Apr 10
|
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
|
|
Apr 2
|
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
|
|
Mar 11
|
Is Masimo (MASI) Outperforming Other Medical Stocks This Year?
|
|
Jan 18
|
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
|
|
Dec 20
|
Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
|
|
Nov 29
|
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
|
|
Nov 14
|
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
|
|
Oct 31
|
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference
|
|
Aug 23
|
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
|
|
Aug 21
|
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
|